1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（微信公号信息）：

https://journals.lww.com/spres/pages/default.aspx

4、投稿网址：

https://www.editorialmanager.com/spres/default.aspx

5、官网邮箱：spineresearch@pub.hep.cn

6、出刊日期：季刊，一年出版四期。

7、官网信息：不收APC。

8、微信公号：SpineR（微信公号“威科医学”信息）

2025年5月21日星期三

Instructions for Authors

【官网信息】

The

Editorial Office is pleased to answer any questions you may have about

preparing your manuscript in accordance with our guidelines.

Email: spineresearch@pub.hep.cn

AIMS AND SCOPE

As

an international, peer-reviewed, open access research publication,

Spine Research publishes the foremost progress and novel understanding

of all aspects of spine science, including basic science, clinical

investigations and medical engineering. The aim of the Journal is to

foster the worldwide dissemination of research in spine-related

physiology, pathology, diseases, treatment and innovative technology, as

well as other significant findings related to spine.

ONLINE SUBMISSION

First-time Users

Please

click the Register button at

https://www.editorialmanager.com/spres/default.aspx. Upon successful

registration, you will be sent an email providing your username and

password. Save this information for future reference.

Note:

If you have received an email from us with an assigned username and

password, or if you are a repeat user, do not register again. Once you

have an assigned username and password, you do not have to re-register.

Authors

Please

click the Login button from the menu at the top of the page and login

to the system as an author. Submit your manuscript according to the

author instructions. You will be able to track the process of your

manuscript through the system.

JOURNAL POLICIES

Duplicate Publication

Manuscripts

are reviewed for possible publication with the understanding that they

are being submitted only to the Spine Research and have not been

published, simultaneously submitted, or already accepted for publication

elsewhere. The Editorial team may subject any manuscript submitted for

consideration of publication in the Spine Research to

plagiarism-detection software.

This

does not preclude consideration of a manuscript that has been rejected

by another journal or a complete report that follows publication of

preliminary findings elsewhere, usually in the form of an abstract.

Copies of any possibly duplicate published material should be submitted

with the manuscript under consideration, with a statement in the cover

letter as to why the manuscript currently being submitted is not a

duplicate publication.

Disclosure of Conflicts

Authors

must state all possible conflicts of interest in the manuscript,

including financial, consultant, institutional and other relationships

that might lead to bias or a conflict of interest. If there is no

conflict of interest, this should also be explicitly stated as none

declared. All sources of funding should be acknowledged in the

manuscript.

All

relevant conflicts of interest and sources of funding should be

included on the title page of the manuscript with the heading "Conflicts

of Interest” and “Source of Funding".

For

example: “Conflicts of Interest: A has received honoraria from Company

Z. B is currently receiving a grant (#12345) from Organization Y, and is

on the speaker's bureau for Organization X - the CME organizers for

Company A. For the remaining authors none were declared.”

“Source of Funding”: list all the grant supports/funders for the study.

A

financial disclosure section is part of the submission process and must

be completed by each author at first revision. This information is for

review by the Editors but will be published if relevant to the content

of the accepted manuscript.

The

primary purpose of the disclosure section is to determine whether

authors have received any commercial financial support that could create

a conflict of interest. In addition to monetary interests, a potential

for conflict of interest can exist whether or not an individual believes

that a relationship (such as dual commitments, competing interests, or

competing loyalties) affects his or her scientific judgment. Please

review ICMJE Uniform Requirements for Manuscripts Submitted to

Biomedical Journals at the following link:

http://www.icmje.org/conflicts-of-interest.

Studies in Humans and Animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

Authors

should include a statement in the manuscript that informed consent was

obtained for experimentation with human subjects. The privacy rights of

human subjects must always be observed.

Authors

describing studies involving animals must have consulted the ‘Animal

Research: Reporting In Vivo Experiments’ (ARRIVE) 2.0 guidelines,

developed by the NC3Rs to improve standards of reporting, ensuring that

the data from animal experiments can be fully scrutinized and utilized.

Articles reporting in vivo experiments must adhere to the ARRIVE

Essential 10 checklist as a minimum, and we encourage authors to use the

full ARRIVE 2.0 checklist. The relevant information outlined in these

guidelines should be included in the appropriate section of the article.

Ethics

When

reporting studies on human subjects, author should indicate whether the

procedures followed were in accordance with the ethical standards of

the responsible committee on human experimentation (institutional or

regional) and with the Declaration of Helsinki

(https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

). For prospective studies involving human participants, authors are

expected to mention about approval of regional/national/institutional or

independent ethics committee or review board, obtaining informed

consent from adult research participants and obtaining assent for

children aged over 7 years participating in the trial. The age beyond

which assent would be required could vary as per regional and/or

national guidelines. Ensure confidentiality of subjects by desisting

from mentioning participants’ names, initials or hospital numbers,

especially in illustrative material. When reporting experiments on

animals, indicate whether the institution’s or a national research

council’s guide for, or any national law on the care and use of

laboratory animals was followed.

Evidence

for approval by a local ethics committee (for both human as well as

animal studies) must be supplied by the authors on demand. Animal

experimental procedures should be as humane as possible, and the details

of anesthetics and analgesics used should be clearly stated. The

ethical standards of experiments must be in accordance with the

guidelines provided by the ARRIVE and World Medical Association

Declaration of Helsinki on Ethical Principles for Medical Research

Involving experimental animals and human beings, respectively. The

journal will not consider any paper which is ethically unacceptable. A

statement on ethics committee permission and ethical practices must be

included in all research articles under the “Methods” section.

We

reserve the right to decline publication of a paper even after it has

been accepted if it becomes apparent that there are serious problems

with the scientific content or violations of our publishing policies.

Protection of Patients’ Rights to Privacy

Identifying

information should not be published in written descriptions,

photographs, sonograms, CT scans, etc., and pedigrees unless the

information is essential for scientific purposes and the patient (or

parent or guardian, wherever applicable) gives written informed consent

for publication. Authors should remove patients’ names from figures

unless they have obtained written informed consent from the patients.

The journal abides by ICMJE guidelines: (1) Authors, not the journals

nor the publisher, need to have the patient consent form before the

publication related to patient privacy and have the form properly

archived by the author. (2) If the publication includes some facial

images that make the patients identifiable, a statement about the

patient’s consent needs to be present in the manuscript.

......

更多详见：

https://journals.lww.com/spres/Pages/informationforauthors.aspx